Drug
Neupro
Neupro is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Phase Distribution
Ph phase_1
1
25%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
Phase 1Safety & dosage
1(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Other(1)
Detailed Status
Completed3
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 11 (100.0%)
Trials by Status
completed375%
unknown125%
Recent Activity
0 active trials
Showing 4 of 4
unknown
The Practical Effect of Neupro
NCT04957420
completedphase_1
Pharmacokinetics and Safety Study of LY03003 in Patients With Early-stage Parkinson's Disease
NCT02055274
completed
Caregivers' and Physicians' Treatment Preference in Parkinson Patients Treated With Neupro® Requiring Caregiver Support
NCT01330290
completed
Non-interventional Study (NIS) in Patients With Restless Legs Syndrome in Daily Practise
NCT01113710
Clinical Trials (4)
Showing 4 of 4 trials
NCT04957420
The Practical Effect of Neupro
NCT02055274Phase 1
Pharmacokinetics and Safety Study of LY03003 in Patients With Early-stage Parkinson's Disease
NCT01330290
Caregivers' and Physicians' Treatment Preference in Parkinson Patients Treated With Neupro® Requiring Caregiver Support
NCT01113710
Non-interventional Study (NIS) in Patients With Restless Legs Syndrome in Daily Practise
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4